POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (10.15.2021, 4:32pm CEST, WHO):   U.S. 97,320    India 16,862    Brazil 7,852    United Kingdom 44,556    Russia 32,196    Turkey 30,709    France 4,877    Iran 11,964    Argentina 1,314    Columbia 1,256    Italy 2,666    Germany 11,518    Mexico 6,320    Poland 2,770    Philippines 7,835    Ukraine 13,624    Malaysia 8,084    Netherlands 3,662    Iraq 2,383    Thailand 10,486    Czechia 1,535    Canada 2,659    Chile 1,191    Romania 15,828    Israel 1,325    Pakistan 1,016    Serbia 6,786    Kazakhstan 2,096    Cuba 2,364    Vietnam 4,151    Hungary 1,249    Austria 2,210    Greece 2,572    Georgia 3,270    Belarus 2,052    Costa Rica 1,170    Bulgaria 3,183    Azerbaijan 1,448    Slovakia 1,952    Croatia 1,758    Ireland 1,626    Venezuela 1,441    Lithuania 2,867    South Korea 1,684    Mongolia 2,076    Moldova 1,666    Slovenia 1,081    Armenia 1,765    Latvia 2,142    Estonia 1,275    China 19    Singapore 2,932    New Zealand 66    Australia 2,752   

Belgium suspends use of Johnson & Johnson vaccine for under 41s

Christian Fernsby |
The Belgian government decided on Wednesday to temporarily stop administering the Johnson & Johnson/Janssen single-dose coronavirus vaccine to people younger than 41 following the death of a woman from severe side-effects after receiving the jab.

Article continues below

"The Inter-ministerial Conference has decided to temporarily administer Janssen's vaccine to the general population from the age of 41 years, pending a more detailed benefit-risk analysis by the European Medicines Agency (EMA)," Belgium's federal and regional health ministers said in a statement.

The woman, who was under the age of 40, died on May 21 in Belgium after suffering from severe thrombosis and platelet deficiency, the statement said.

On April 20, the EMA's safety committee said that there was a possible link between rare blood clots and the Johnson & Johnson vaccine, but refrained from recommending an age limit.

Belgium will now offer people under 41 a new vaccine, which could cause delays in the country's vaccination campaign, as the Johnson & Johnson vaccine only required one dose.

"If we cannot count on those vaccines, we will only achieve 85 percent vaccination coverage by July 11," Flemish Welfare Minister Wouter Beke said.

The Johnson & Johnson vaccine will continue to be used for the elderly and those in precarious situations, such as the homeless.

Belgium has recorded a total of 1,050,677 COVID-19 cases and 24,873 deaths since the beginning of the pandemic.

What to read next

Several U.S. states shut down Johnson & Johnson vaccine sites after adverse reactions reported
World-first COVID-19 alternating dose vaccine study launches in UK
WHO approves Sinopharm COVID-19 vaccine for emergency use